• Home
  • Team
  • Services
  • Portfolio
    • Cleantech
      • Consulting Energy Control
      • Lumartix
      • PVSyst
    • Healthcare
      • Anteis
      • Augurix
      • BioXpress Therapeutics
      • Leman Medical Technologies
      • Medicontur
      • Powersens
      • Viroblock
    • ICT
      • Abilis
      • inZair
      • Tegona
    • IT
      • salsaDev
    • Life Sciences
      • Selexis
    • Nanotechnology
      • Dextens
      • Manep
      • Phasis
  • Partners
    • VentureLab
    • Venture Kick
    • CTI
    • CTI Startup
    • CTI Invest
    • AlpICT
    • CleantechAlps
    • Eclosion
    • Economic Development Service
    • OPI
    • HUG
    • UNITEC
    • MedC Partners
    • BlueOcean Ventures
    • Business Angels Switzerland
    • Startup Weekend
  • FAQ
  • News
  • Investors
  • Accelerators
  • Workshops
  • Jobs Board
  • Apply
  • Contact

FONGIT

The Start up Factory - T +41(0)22 884-8300

Powersens

January 20, 2012 by admin

Powersens is a start up developing and selling smart electronic shoe-insoles for the medical market. The insoles placed inside the shoe, monitors and records foot plantar pressure and body movement throughout the day.

 

They help users for interactive walking/sport rehabilitation and can diagnostic orthopaedic complications such as diabetic foot ulcers. This high potential medical device will improve lifetime and health conditions of millions of people.

Filed Under: Diagnostic, Featured, Fongit, Foot, Healthcare, MedTech, Orthopaedic, Plantar pressure, Sensors, Shoe-insole, Sport

Dextens

May 5, 2011 by admin

Dextens develops, produces and commercializes measurement instruments for the beverage, semiconductor, steam power, pharmaceutical and chemical industries. Our instruments determine oxygen, ozone, carbon dioxide, hydrogen and nitrogen levels in both liquid and gaseous mediums and are ideal for high precision measurement in harsh conditions. The full development and optimization of products is carried out internally and the production is outsourced to Swiss manufacturers. Thus far, we have a set up a solid distribution network in Europe, the Americas, Asia and Australia, and looks at expanding and strengthening its presence worldwide. Our revenue streams come by replacing installed products from competitors and by entering into market segments with new applications.

Filed Under: Dextens, Featured, Fongit, Sensors

VentureKick VentureLab Aesthetic dermatology (1)
AFM (1)
Antibodies (1)
Artery banding (1)
Augurix (1)
Bio-therapeutics (1)
Biopolymers (1)
Biosimilar (2)
BlueOcean Ventures (1)
Cataract (1)
Cell-based assay (1)
Cell-line development (1)
Cleantech (2)
Consulting (2)
Content Analytics (1)
CTI (3)
CTI Start up (2)
Dextens (1)
Diagnostic (1)
Epigenetics (1)
Featured (10)
FloWatch (1)
Fongit (13)
Fongit Seed Invest (5)
Foot (1)
Funding (4)
Gaming (1)
gene expression (1)
Geolocalisation (1)
Hard skills (1)
Healthcare (5)
Injectable (1)
InjectNow (1)
Innovation (3)
Intraocular lens implant (1)
Investment (3)
Legal (1)
MedTech (3)
Messaging (1)
Metallurgy (1)
Micro-credit (1)
Micro-health (1)
Micro-insurance (1)
Microscopy (1)
Microscopy substrate (1)
NFC (1)
Ophthalmology (1)
Orthopaedic (1)
Orthopaedics (1)
PAB (1)
Plantar pressure (1)
Private Equity (1)
Protein expression (1)
Protein production (1)
R&D (1)
Recombinant proteins (1)
Recruiters (1)
SalsaDev (1)
Security (1)
Semantic (1)
Semantic Meaning (1)
Sensors (2)
Shoe-insole (1)
Smartcard (1)
Soft skills (1)
Space-time (1)
Sport (1)
STM (1)
Superconductor (1)
Talent matching (1)
Thin film (2)
Training (1)
Value network (1)
Venture Capital (3)
Viroblock (2)
Wireless (1)
Workshops (2)
ZMS (1)

WP Cumulus Flash tag cloud by Roy Tanck requires Flash Player 9 or better.

Return to top of page

Copyright FONGIT © 2013 · Terms of Use · Log in